Does Open Reduction and Internal Fixation versus Primary Arthrodesis Improve Patient Outcomes for Lisfranc Trauma? A Systematic Review and Meta-analysis
- First Online:
- Cite this article as:
- Smith, N., Stone, C. & Furey, A. Clin Orthop Relat Res (2016) 474: 1445. doi:10.1007/s11999-015-4366-y
- 2k Downloads
Although Lisfranc injuries are uncommon, representing approximately 0.2% of all fractures, they are complex and can result in persistent pain, degenerative arthritis, and loss of function. Both open reduction and internal fixation (ORIF) and primary fusion have been proposed as treatment options for these injuries, but debate remains as to which approach is better.
We asked whether ORIF or primary fusion led to (1) fewer reoperations for hardware removal; (2) less frequent revision surgery; (3) higher patient outcome scores; and (4) more frequent anatomic reduction.
A systematic review was performed using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Three trials met the criteria for inclusion within the meta-analysis. Qualifying articles for the meta-analysis had data extracted independently by two authors (NS, AF). The quality of each study was assessed using the Center for Evidence Based Medicine’s evaluation strategy; data were extracted from articles rated as good and fair: two and one article, respectively.
The risk ratio for hardware removal was 0.23 (95% confidence interval [CI], 0.11–0.45; p < 0.001) indicating more hardware removal for ORIF than fusion. For other revision surgery, the risk ratio for ORIF was 0.36 (95% CI, 0.08–1.59; p = 0.18) favoring neither. Similarly, neither was favored using patient-reported outcomes; the standard mean difference was calculated to be 0.50 (95% CI, −2.13 to 3.12; p = 0.71). When considering the risk of nonanatomic alignment, neither was favored (risk ratio, 1.48; 95% CI, 0.34–6.38; p = 0.60).
The surgeon should consider the increased risk of hardware removal along with its associated morbidity and discuss this with the patient preoperatively when considering ORIF of Lisfranc injuries. Because no new trials have been performed since 2012, further randomized controlled trials will be needed improve our understanding of these interventions.
Level of Evidence
Level I, therapeutic study.
The Lisfranc ligament runs on the plantar aspect of the foot from the lateral aspect of the medial cuneiform to the medial aspect of the second metatarsal . It functions to stabilize the tarsometatarsal articulation of the foot and injury to the ligament can lead to substantial pain, midfoot arthritis, decreased function, and loss of quality of life . This is a relatively rare injury with an incidence of approximately 0.2% of all fractures  although it is frequently diagnosed late and this leads to poor functional outcomes for the patient . It has been demonstrated that anatomic reduction and rigid stabilization of the Lisfranc complex is the standard of care for these injuries . Open reduction and internal fixation (ORIF) and primary arthrodesis have both been evaluated as treatment options with acceptable results .
Debate remains over which approach, ORIF or primary fusion, leads to better function and less pain. A systematic review in 2012 included data from six studies, compared American Orthopaedic Foot and Ankle Society Scores (AOFAS) and the percentage of patients achieving anatomic reduction between the ORIF and primary arthrodesis groups, and concluded that both methods were acceptable. The quality of evidence was low and more direct comparative trials would be needed . However, their search criteria were not clearly defined and they did not perform a methodologically strong systematic review. A 2012 systematic review of three trials (two randomized controlled trials [RCTs] and one comparative series) likewise concluded that neither approach was superior based on the available literature and further trials would be needed to improve the evidence , but that study did not include an in-depth examination of the gray literature and non-English language articles were excluded. They recommended that further RCTs be performed to improve the outcome knowledge of these procedures. We sought to update the currently available literature with a clearly defined systematic review and pool the results in a meta-analysis. The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines were adhered to throughout the study . The purpose of this systematic review is to determine if patients who sustain acute traumatic Lisfranc injuries, either purely ligamentous or bony, achieve improved patient outcomes with primary fusion compared with ORIF in terms of (1) hardware removal; (2) revision surgery; (3) patient outcome measures; and (4) anatomic reduction.
Search Strategy and Criteria
RCTs and cohort studies comparing ORIF with primary arthrodesis were included in the evaluation. All human, comparative studies were included. Non-English studies were examined and translated if appropriate and possible.
Search Strategy and Information Sources
We searched the PubMed, EMBASE, and Cochrane databases in October 2014. No restrictions were placed on the search engines. Our initial search was performed in PubMed using terms to describe the anatomic location, injury type, and intervention. Lisfranc injuries were captured using the terms: “metatarsal bones”[Mesh], Lisfranc [tiab], midfoot [tiab], “tarsal joints”[Mesh], and “tarsal bones”[Mesh]. Injury type was found using the keyword search “fracture” and the Mesh term “dislocations”. Finally, surgical intervention was found using the terms: fixation [tiab], “fracture fixation”[Mesh], “fracture fixation, internal”[Mesh], fusion [tiab], and “arthrodesis”[Mesh]. All possible combinations of the terms were applied.
This strategy produced 318 papers in PubMed. A similar protocol was undertaken in EMBASE and the Cochrane Library revealing 701 and 263 papers, respectively. Reference lists from relevant articles were examined for further studies. Clinical trial databases from the World Health Organization, Health Canada, and the US National Institutes of Health were explored for registered trials. Only one clinical trial has been registered and although it is actively recruiting patients, it has yet to produce clinical outcomes.
Study Selection and Data Collection Process
Summary of articles in this meta-analysis
Assessment of potential bias of studies selection for inclusion in the synthesis using USPSTF Quality Rating Criteria
Assembly of comparable groups
Maintenance of comparable groups
No important differential loss to follow-up or overall high loss to follow-up
Measurements: equal, reliable, valid (includes masking of outcome assessment)
Clear definition of interventions
All important outcomes considered
Analysis: adjustment for potential confounders
Overall assessed quality
Henning et al., 2009 
Ly et al., 2006 
Mulier et al., 2002 
For hardware removal risk, we assessed differences in proportions having undergone hardware removal. We included two studies that reported on this outcome variable. For repeat surgery, we evaluated risk of return to the operating room for reasons other than hardware removal. All three studies discuss the reasons for repeat surgery including: hardware failure, posttraumatic arthritis, and loss of reduction. For patient-reported outcomes, Henning used the Short Musculoskeletal Functional Assessment and the SF-36. Incomplete statistical sets were available for a meta-analysis and this study could not be included. Complete statistical data were available for Ly et al. , who used the AOFAS scale, and for Mulier who used the Baltimore Painful Foot score. Different scales were present; therefore, we assessed standard mean differences.
We also evaluated the risk ratio of nonanatomic alignment. Proportions of anatomic reduction radiographically were compared using risk ratios for the two techniques. All three studies reported on this measure. Heterogeneity was assessed using the I2 measure. Random-effects models were used for all statistical calculations given the heterogeneity noted between the studies along with the Mantel-Haenszel formula. Discrete variables were analyzed using risk ratios, whereas continuous variables were analyzed with standard mean difference.
Patient Outcome Measures
Lisfranc complex injuries are rare. Their diagnosis can be difficult and when missed, patients have poor reported outcomes . Anatomic reduction has been shown to be the primary determining factor in achieving acceptable outcomes . How to best achieve this result remains debatable . RCTs can be difficult to perform in a timely manner given the relatively rare nature of the injury. Previous systematic reviews contained methodological flaws that bring their results into question. Both previous reviews came to the conclusion that further RCTs would be needed to compare the results of these two procedures. No previous study has attempted to perform a meta-analysis comparing ORIF with primary fusion for acute Lisfranc injuries. Our systematic review revealed one currently registered trial comparing ORIF and primary fusion of Lisfranc injuries head to head. No other trials have been published since the studies from 2012. The purpose of this paper was to perform a methodologically sound systematic review and meta-analysis to determine if the present literature demonstrates a clear advantage to either ORIF or primary arthrodesis for Lisfranc injuries. Four surgical outcomes were examined and the only difference found was in the frequency with which patients subsequently underwent removal of hardware with this taking place more often in patients treated with ORIF.
Although our study represents the most comprehensive systematic review and the only meta-analysis related to this topic, there were still potential sources of error. Only three studies within the literature directly compare ORIF with fusion with a total of 101 patients. This low level of recruitment contributed to the large CIs noted for each of our primary outcomes and highlights the need for more high-quality comparative trials to build on our current knowledge. High levels of heterogeneity between the studies also demonstrate the difficulty in directly comparing the outcomes from each of these trials. Lisfranc injuries represent a wide range of pathology from purely ligamentous to complex open fracture dislocations. Although no studies included open fractures, each study had slightly different inclusion criteria. This will lead to some amount of bias through the comparison of different injury types. Differences in surgical procedures will also contribute to this problem. Most importantly Henning chose to remove the hardware as a standard protocol in his ORIF cohort. Certainly this brings a protocol bias to the positive outcome of increased hardware removal rates in the ORIF group. Even with this built-in removal from Henning, the rates here were similar to those of Ly et al.  with CIs of 0.07 to 0.62 and 0.10 to 0.59, respectively. Also, three patients in the Henning group refused to undergo hardware removal if they were asymptomatic. This would be expected as a likely scenario with a lack of symptoms being a strong reason to deviate from the study protocol. These reasons lessen the concern for the major difference in the hardware removal protocol and allow for the conclusion that the ORIF group undergoes increased removal of hardware.
Each of the individual studies also had design errors that will insert bias into the results of the meta-analysis. Blinding was not well accounted for in any of the studies nor were randomization techniques ideal. This will add to selection bias although this is consistently a problem with surgical outcome studies. Henning’s study was underpowered and there was no power analysis done for Mulier’s work. There was a significant loss to long-term followup within Henning’s paper that weakens their final conclusions. Finally, publication bias may be present in the literature. Our thorough search of the gray literature did not yield any sets of unpublished data. Given the small amount of direct comparative material, it is likely that even small and negative series would add to the available knowledge and the risk of this bias may be low. With only three completed trials, there is no way to examine for publication bias and it must be recognized as a potential confounder. Well-defined comparative trials of similar populations and injury types will help to correct these issues.
The ORIF grouped demonstrated a clear need for increased removal of hardware rates. In considering this positive result, two important factors must be examined. First, Henning et al., as a part of their standard protocol, removed the hardware in 11 of their 14 patients. Three refused stating they were asymptomatic. This protocol bias may have strongly influenced their removal rates. Ly et al.  had similar removal rates without such a standard protocol. Second, only two of the three studies reported on hardware removal. The need for this remains debatable. Certainly this is an extremely important variable for patients to understand given the large impact a second, potentially unnecessary, surgery would have on their lives. Future studies examining the necessity of hardware removal and the patient impact factor of the procedure will be key in determining the superiority of ORIF versus fusion.
Major revision or repeat surgery would have an even greater impact on a patient’s livelihood and satisfaction than simple removal of hardware. A clearly superior and definitive procedure in this category would strongly influence a surgeon to complete one operation over the other. We were unable to demonstrate this difference with a meta-analysis of the currently available patients. RCTs of adequate quality and followup need to be performed to capture this outcome.
Validated patient outcome scores give us a window into the lives of the patients postoperatively. The use of multiple different scales for patient-defined outcomes makes this variable perhaps the most difficult to interpret. Neither procedure demonstrated an advantage over the other. Stavlas et al. performed a systematic review in 2010 examining the role of reduction and internal fixation in the management of Lisfranc injuries . They pooled the results of all reported AOFAS scores within the literature and found the mean score to be 78.1. Since 2010, several case series have been published with mean scores similar or higher than that reported by Stavlas et al. One other comparative trial was found comparing primary ORIF with delayed fusion . This well-designed study compared the results of 22 primary fixations with 22 delayed fusions at a mean of 22 months postinjury. They found higher AOFAS scores in the group fixed primarily compared with the delayed fusion cohort (AOFAS mean 81 versus 72; p = 0.031). With this currently available body of literature, future studies should include the AOFAS measurement for comparative purposes.
Anatomic reduction of the Lisfranc complex has been clearly demonstrated as the most important factor in determining patient outcomes after these injuries. Our inability to show a clearly superior procedure between ORIF and fusion may stem from the fact that reduction rates appear to be similar between the two operations. We were unable to demonstrate a difference in reduction rates. High-quality radiography, either plain film or CT, and clear definitions of reduction are needed for future work.
ORIF outcome measurements
Number of patients
Mean outcome measures
Ghate et al., 2012 
Marin-Pena et al., 2012 
Yang et al., 2011 (abstract only) 
AOFAS 78% > 80
Zhu et al., 2011 (abstract only) 
AOFAS 84.2 ± 2.8
Llano et al., 2010 (abstract only) 
Zhou et al., 2008 (abstract only) 
Rajapaske et al., 2006 
42.6 months (significant loss)
Perugia et al., 2003 
AOFAS 81 ± 13.5
Kuo et al., 2000 
52 months (significant loss)
Mulier et al., 1997 
Using the currently available literature, it was asked if ORIF or primary fusion was clearly superior for acute Lisfranc injuries in terms of removal of hardware, revision surgery, patient outcome scores, or anatomic reduction. Removal of hardware rates appear to be more frequent in patients undergoing ORIF. The need for a second surgery, and the associated negative effect on patient outcomes, must be strongly considered and may lend some surgeons to consider primary fusion as the superior operation. No other differences were established.
When discussing treatment methods with patients, surgeons should consider comorbidities, patient characteristics, fracture pattern, and surgical preferences in their decision-making pathway. Patients undergoing ORIF should be informed of the increased likelihood that they might subsequently undergo removal of hardware compared with a primary fusion. The wide breadth of injury patterns included within the Lisfranc category may introduce too much heterogeneity to conclude that a single procedure is superior in all instances. The results of well-designed, prospective RCTs will be required to further our knowledge of these treatment modalities.